Simvastatin
Rank #197 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$74.4M
Total Cost
6,872,746
Total Claims
$74.4M
Total Cost
91,919
Prescribers
$11
Cost per Claim
1,783,616
Beneficiaries
17,510,385
30-Day Fills
$809
Avg Cost/Provider
75
Avg Claims/Provider
Share of Medicare Part D Spending
0.03%
of total Medicare Part D spending
$74.4M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $74.4M total
🔎 Data Overview
At $11.00 per prescription, this is an affordable generic medication. Wider use of affordable generics like this could save Medicare billions annually.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Simvastatin
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Kevin Vuong | Nurse Practitioner | Sacramento, CA | 821 | $19K |
| 2 | Ashley Theroux | Nurse Practitioner | Haverhill, MA | 1,477 | $17K |
| 3 | Lin Gong | Internal Medicine | Brooklyn, NY | 2,535 | $16K |
| 4 | Mai Phan | Internal Medicine | Reseda, CA | 402 | $16K |
| 5 | Carlos Muniz Molinero | Internal Medicine | Aguada, PR | 3,873 | $15K |
| 6 | Tung Nguyen | Family Practice | San Jose, CA | 696 | $15K |
| 7 | Zaven Arslanian | General Practice | Glendale, CA | 1,562 | $14K |
| 8 | Liliane Kheng | Family Practice | Lihue, HI | 482 | $14K |
| 9 | Natalie Brixey | Family Practice | Tishomingo, OK | 173 | $14K |
| 10 | Singmay Siu | Internal Medicine | Brooklyn, NY | 1,811 | $14K |
| 11 | Xiaoqin Yin | Family Practice | Flushing, NY | 1,817 | $13K |
| 12 | Alberto Rozo | Internal Medicine | Jackson Heights, NY | 979 | $13K |
| 13 | Mitchell Davis | Family Practice | Ada, OK | 155 | $13K |
| 14 | Sandeep Jain | Internal Medicine | Concord, MA | 791 | $13K |
| 15 | Zhaoyang Pan | General Practice | Los Angeles, CA | 1,027 | $12K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 194 | Cannabidiol (Cbd) (Epidiolex) | $75.5M | 15,726 |
| 195 | Eculizumab (Soliris) | $74.6M | 1,794 |
| 196 | Lidocaine (Lidocaine) | $74.4M | 416,864 |
| 197 | Simvastatin (Simvastatin) | $74.4M | 6,872,746 |
| 198 | Sertraline Hcl (Sertraline Hcl) | $74.3M | 6,472,210 |
| 199 | Pirfenidone (Pirfenidone) | $74.1M | 17,775 |
| 200 | Escitalopram Oxalate (Escitalopram Oxalate) | $73.6M | 4,975,143 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology